-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J+9ihHbqvrs2YICr1FXJjygvxzaXEbYyTTW/3xfmo9RRzwiKdELxCQawuKBhCjOt 05HnrzlrfTeNggYqb/gvdA== 0001140361-07-006357.txt : 20070327 0001140361-07-006357.hdr.sgml : 20070327 20070327151407 ACCESSION NUMBER: 0001140361-07-006357 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070326 FILED AS OF DATE: 20070327 DATE AS OF CHANGE: 20070327 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5105741400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iwanicki David CENTRAL INDEX KEY: 0001322481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 07721143 BUSINESS ADDRESS: BUSINESS PHONE: 510-574-1400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc1.xml FORM 4 X0202 4 2007-03-26 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001322481 Iwanicki David C/O PDL BIOPHARMA, INC. 34801 CAMPUS DRIVE FREMONT CA 94555 0 1 0 0 VP, Sales & Sales Operations Common Stock 2007-03-26 4 M 0 2187 15.73 A 2187 D Common Stock 2007-03-26 4 S 0 219 20.13 D 1968 D Common Stock 2007-03-26 4 S 0 438 20.14 D 1530 D Common Stock 2007-03-26 4 S 0 219 20.17 D 1311 D Common Stock 2007-03-26 4 S 0 218 20.18 D 1093 D Common Stock 2007-03-26 4 S 0 219 20.25 D 874 D Common Stock 2007-03-26 4 S 0 437 20.29 D 437 D Common Stock 2007-03-26 4 S 0 219 20.34 D 218 D Common Stock 2007-03-26 4 S 0 218 20.71 D 0 D Employee Stock Option (Right to Buy) 15.73 2007-03-26 4 M 0 2187 0 D 2015-04-18 Common Stock 2187 52506 D Sale was made pursuant to a 10b5-1 plan established by the reporting person. Option vests with respect to approximately 2,187.5 shares per month and 6 shares remained exercisable immediately after this transaction. Only vested options are exercisable /s/ Francis Sarena by Francis Sarena, Attorney in Fact for David Iwanicki 2007-03-27 -----END PRIVACY-ENHANCED MESSAGE-----